Literature DB >> 16108394

Local estrogen replacement therapy in postmenopausal atrophic vaginitis: efficacy and safety of low dose 17beta-estradiol vaginal tablets.

G Mainini1, C Scaffa, M Rotondi, E M Messalli, L Quirino, A Ragucci.   

Abstract

PURPOSE OF INVESTIGATION: To verify the effectiveness and safety of low-dose 17beta-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis. PATIENTS AND METHODS: 325 postmenopausal women with atrophic vaginitis in estrogenic replacement therapy with 0.025 mg 17beta-estradiol vaginal tablets, one application each day for two weeks, and a single application two times a week for the following 22 weeks (total treatment period: 24 weeks).
RESULTS: Most of the women reported an improvement of symptoms just after two weeks and minimal incidence of adverse reactions. No patients showed abnormal endometrial thickness and no one had to interrupt the treatment for abnormal uterine bleeding because of systemic absorption.
CONCLUSION: Low-dose 17beta-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis constitutes an extremely valid approach in terms of effectiveness and safety.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16108394

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  3 in total

1.  Efficacy and safety of ultra-low-dose Vagifem (10 mcg).

Authors:  Janet A Chollet
Journal:  Patient Prefer Adherence       Date:  2011-11-11       Impact factor: 2.711

2.  Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review.

Authors:  Ginger D Constantine; Shelli Graham; Kate Lapane; Kathleen Ohleth; Brian Bernick; James Liu; Sebastian Mirkin
Journal:  Menopause       Date:  2019-07       Impact factor: 2.953

3.  Effect of Vaginal Estriol Use in Total Laparoscopic Hysterectomy with Gonadotropin-Releasing Hormone Agonist Therapy.

Authors:  Go Hirata; Hiroshi Yoshida; Atsuko Furuno; Masakazu Kitagawa; Hideya Sakakibara
Journal:  Gynecol Minim Invasive Ther       Date:  2018-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.